Compare Stocks

Liquefied Natural Gas Limited, together with its subsidiaries, engages in the identification and progression of liquefied natural gas (LNG) development projects to facilitate the production and sale of LNG. It operates through LNG Infrastructure, and Technology and Licensing segments. The company's projects include the Magnolia LNG project located in Lake Charles, Louisiana, the United States; and the Bear Head LNG project situated in Point Tupper, Richmond County, Nova Scotia, Canada. It also designs, develops, owns, and patents OSMR LNG liquefaction process. The company is headquartered in Houston, Texas.

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Noble Group Limited is in the process of liquidation. Previously, the company was operated as an independent energy products and industrial raw materials supply chain manager. Its Energy segment was engaged in trading energy coal and the provision of supply chain and risk management services in bituminous and sub-bituminous energy coal, as well as in seaborne LNG. The company's Metals, Minerals and Ores segment was involved in trading and providing supply chain management services in copper, zinc, lead, nickel, and other raw materials, as well as aluminum, alumina, and bauxite. The company was also engaged in trading and providing risk management and logistics services for the steel complex in iron ore, metallurgical coal, metallurgical coke, specialty ores and alloys, and industrial metals and minerals, as well as offered ocean transport in the dry bulk segment, long term freight solutions, and freight market guidance. The company was founded in 1987 and is headquartered in London, the United Kingdom.

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Thomas Cook Group Plc engages in the provision of travel services. The company was founded on February 8, 2007 and is headquartered in Manchester, the United Kingdom.